01-06-1999 | ORIGINAL ARTICLE
Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures
Published in: Rheumatology International | Issue 5-6/1999
Login to get access